Somatropin biosimilar (Jilin Qijian BioPharma)

生长激素类似物 (吉林省奇健生物)

Report date: 2025/01/07 11:28:53

Base Information

Drug NameSomatropin biosimilar (Jilin Qijian BioPharma)
Drug Alias Name生长激素生物类似物生长激素生物仿制药
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyGrowth DisordersRenal Insufficiency, Chronic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJilin Qijian Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJilin Qijian Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyGrowth DisordersRenal Insufficiency, Chronic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A